Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Locally-advanced Rectal Cancer × Capecitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 39 Pancreatic Neoplasms 29 Rectal Neoplasms 28 Colorectal Neoplasms 28 Neoplasms 25 Stomach Neoplasms 19 Neoplasm Metastasis 14 Colonic Neoplasms 12 Unspecified Adult Solid Tumor, Protocol Specific 11 Esophageal Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Solid Tumor 7 Biliary Tract Neoplasms 7 Carcinoma, Hepatocellular 4 Bile Duct Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Liver Neoplasms 3 Head and Neck Neoplasms 3 Gallbladder Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Appendiceal Neoplasms 3 Anus Neoplasms 3 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms, Unknown Primary 2

Interventions

Oxaliplatin 1 Folfox protocol 1 Capecitabine 1 ASTX-660 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05912075 2024-02-08

PRAAR1

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Recruiting

Gastrointestinal

Locally-advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡